NOZAX

NOZAX is a retail forex and CFD broker with a legal name of NOZAX AD. The company is based in Podgorica, Montenegro, with a registered address at Ankarski bulevar 12, 81000 Podgorica. While the firm’s own marketing materials cite a founding year of 2017, public records indicate an incorporation date of 15 August 2022. This discrepancy is one of several irregularities that prospective clients should note.

The broker caters primarily to retail traders and has gained traction in Southeast Asian markets, particularly Indonesia. Its offerings centre on forex, indices, and commodities, with a notable emphasis on low-cost trading and localised payment solutions.

NOZAX operates under a Derivatives Trading Licence (STP) issued by the Capital Market Authority of Montenegro (SCMN), licence number 03/2-5/5-21. Montenegro’s financial regulator is not considered a top-tier authority, and its oversight framework is less stringent than that of FCA, CySEC, or ASIC. This means that while the broker is technically regulated, client protections such as mandatory insurance schemes or segregated account guarantees may be more limited.

The SCMN licence permits NOZAX to offer straight-through processing (STP) brokerage services. However, traders should be aware that the regulator’s capacity for enforcement and dispute resolution is relatively modest compared to larger jurisdictions. The licence alone should not be taken as a robust safety net.

NOZAX offers three live account tiers: CENT, CORE, and ZERO. All accounts provide a maximum leverage of 1:500, which is extremely high and amplifies both potential profits and losses. The CENT account is a micro-lot account that allows trading in forex, gold, and silver with no commission, making it suitable for beginners who want to risk very small amounts. The CORE account expands the instrument range to include indices and commodities, also commission-free. The ZERO account targets experienced traders by advertising raw spreads from 0.0 pips but charges a $2 commission per side (in and out).

Notably, the broker does not disclose minimum deposit requirements for any account. This lack of transparency can be a red flag, as it leaves potential clients guessing about the initial capital needed to start trading.

The broker’s tradable instruments are concentrated in forex, indices, and commodities. While the company description also mentions shares, the structured data from the broker does not list share CFDs among the available products, creating an inconsistency. Traders seeking a broader asset selection, including stocks or cryptocurrencies, may find the range limiting.

NOZAX supports the widely used MetaTrader 5 (MT5) platform, known for its advanced charting tools, algorithmic trading capabilities, and customisable indicators. The broker claims to offer real-time technical analysis and a stable trading environment, which aligns with positive user reviews regarding platform performance.

Funding methods include bank transfer, VISA, Mastercard, and the e-wallet Skrill. The broker emphasises fast processing for both deposits and withdrawals. User reviews frequently mention the convenience of local bank integration, particularly for Indonesian rupiah (IDR) transactions, which caters to its Southeast Asian client base.

However, the presence of 13 withdrawal-related complaints and at least one public review describing a failed withdrawal with no explanation indicates that payment reliability is not universal. Traders should approach with caution and verify withdrawal efficiency with a small test amount before committing larger sums.

NOZAX may appeal to traders who prioritise low trading costs, high leverage, and localised support in Southeast Asia. The CENT account is especially attractive for absolute beginners who want to trade micro-lots with minimal risk. Indonesian traders benefit from IDR-denominated accounts and local bank transfer options.

On the other hand, the broker is less suitable for those who require the safety of a top-tier regulator, a wide array of instruments, or guaranteed withdrawal reliability. The “Guarded” risk score and discrepancies in company information suggest that NOZAX is best approached with modest capital and a clear exit strategy.